Compounds > homovanillic acid

homovanillic acid and 1-methyl-1,2,3,4-tetrahydroisoquinoline

homovanillic acid has been researched along with 1-methyl-1,2,3,4-tetrahydroisoquinoline in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antkiewicz-Michaluk, L; Lorenc-Koci, E; Michaluk, J; Mokrosz, M; Ohta, S; Romanska, I; Vetulani, J1
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T1
Antkiewicz-Michaluk, L; Bojarski, AJ; Karolewicz, B; Michaluk, J; Romańska, I; Vetulani, J1
Antkiewicz-Michaluk, L; Bojarski, A; Michaluk, J; Romańska, I; Wąsik, A1
Antkiewicz-Michaluk, L; Michaluk, J; Romańska, I; Wąsik, A1

Other Studies

5 other study(ies) available for homovanillic acid and 1-methyl-1,2,3,4-tetrahydroisoquinoline

ArticleYear
Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
    Journal of neurochemistry, 2001, Volume: 78, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Homovanillic Acid; Isoquinolines; Male; Motor Activity; Muscle Rigidity; Nucleus Accumbens; Rats; Rats, Wistar; Substantia Nigra; Tetrahydroisoquinolines

2001
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
    Brain research bulletin, 2001, Sep-01, Volume: 56, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase

2001
1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
    European journal of pharmacology, 2003, Apr-18, Volume: 466, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Homovanillic Acid; Insecticides; Isoquinolines; Male; Nucleus Accumbens; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Survival Rate; Tetrahydroisoquinolines

2003
Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release.
    Neurotoxicity research, 2011, Volume: 20, Issue:2

    Topics: Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Drug Administration Schedule; Homovanillic Acid; Injections, Subcutaneous; Insecticides; Male; Microdialysis; Motor Activity; Rats; Rats, Wistar; Rotenone; Stereoisomerism; Tetrahydroisoquinolines; Time Factors

2011
Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats.
    Neurotoxicity research, 2017, Volume: 32, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Clonidine; Depression; Disease Models, Animal; Freezing Reaction, Cataleptic; Homovanillic Acid; Locomotion; Male; Neuroprotective Agents; Psychomotor Performance; Rats; Rats, Wistar; Swimming; Sympatholytics; Tetrahydroisoquinolines

2017